Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: Role of silent information regulator 1

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Yu, Liming ^a   Li, Qing ^b   Yu, Bo ^a   Yang, Yang ^c   Jin, Zhenxiao ^a   Duan, Weixun ^a   Zhao, Guolong ^d   Zhai, Mengen ^a   Liu, Lijun ^e   Yi, Dinghua ^a   Chen, Min ^a   Yu, Shiqiang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d NINGXIA MEDICAL UNIVERSITY   (China)

^e NORTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; OXYGEN;

ANTI-INFLAMMATORY ACTIVITY; ANTI-INFLAMMATORY EFFECTS; CARDIOPROTECTIVE EFFECT; LACTATE DEHYDROGENASE; MYOCARDIAL ISCHEMIA; SPRAGUE-DAWLEY RATS; SUPEROXIDE DISMUTASES; SUPEROXIDE GENERATION;

PATHOLOGY;

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BERBERINE; CASPASE 3; CREATINE KINASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SILENT INFORMATION REGULATOR PROTEIN; SILENT INFORMATION REGULATOR PROTEIN 1; SIRTINOL; SIRTUIN 1; SMALL INTERFERING RNA; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; NAPHTHOL DERIVATIVE; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; APOPTOTIC INDEX; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOWN REGULATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BLOOD; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL LINE; CHEMISTRY; DRUG EFFECTS; HEART FUNCTION TEST; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZAMIDES; BERBERINE; CASPASE 3; CELL LINE; CELL SURVIVAL; CREATINE KINASE; FORKHEAD TRANSCRIPTION FACTORS; HEART FUNCTION TESTS; INFLAMMATION; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NAPHTHOLS; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIRTUIN 1;

EID: 84953897485     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1689602     Document Type: Article

References (44)

1. D. J. Hausenloy and D. M. Yellon, "Myocardial ischemiareperfusion injury: a neglected therapeutic target," The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92-100, 2013.
2. A. L. Müller, L. V. Hryshko, and N. S. Dhalla, "Extracellular and intracellular proteases in cardiac dysfunction due to ischemiareperfusion injury," International Journal of Cardiology, vol. 164, no. 1, pp. 39-47, 2013.
3. S. R. J. Maxwell and G. Y. H. Lip, "Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options," International Journal of Cardiology, vol. 58, no. 2, pp. 95-117, 1997.
4. G. Petrosillo, F. M. Ruggiero, N. Di Venosa, and G. Paradies, "Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin," The FASEB Journal, vol. 17, no. 6, pp. 714-716, 2003.
5. J. L. Zweier and M. A. H. Talukder, "The roleofoxidants and free radicals in reperfusion injury," Cardiovascular Research, vol. 70, no. 2, pp. 181-190, 2006.
6. M. Tillhon, L. M. Guaman Ortiz, P. Lombardi, and A. I. Scovassi, "Berberine: new perspectives for old remedies," Biochemical Pharmacology, vol. 84, no. 10, pp. 1260-1267, 2012.
7. M. Imanshahidi and H. Hosseinzadeh, "Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine," Phytotherapy Research, vol. 22, no. 8, pp. 999-1012, 2008.
8. C.-L. Kuo, C.-W. Chi, and T.-Y. Liu, "The anti-inflammatory potential of berberine in vitro and in vivo," Cancer Letters, vol. 203, no. 2, pp. 127-137, 2004.
9. F. R. Stermitz, P. Lorenz, J. N. Tawara, L. A. Zenewicz, and K. Lewis, "Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor," Proceedings of theNationalAcademy of Sciences of theUnited States ofAmerica, vol. 97, no. 4, pp. 1433-1437, 2000.
10. X.-H. Zeng, X.-J. Zeng, and Y.-Y. Li, "Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy," The American Journal of Cardiology, vol. 92, no. 2, pp. 173-176, 2003.
11. P. Zhang, D. Ma, Y. Wang et al., "Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice," Food and Chemical Toxicology C, vol. 74, pp. 225-232, 2014.
12. F. Gao, Y. Gao, Y.-F. Liu, L. Wang, and Y.-J. Li, "Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat," Neuropsychiatric Disease and Treatment, vol. 10, pp. 2139-2145, 2014.
13. L. Chi, L. Peng, X. Hu, N. Pan, and Y. Zhang, "Berberine combined with atorvastatin downregulates LOX-1 expression through the ET-1 receptor in monocyte/macrophages," International Journal ofMolecularMedicine, vol. 34, no. 1, pp. 283-290, 2014.
14. J. Gao, Y.-Q. Tang, D.-Z. Dai et al., "Raisanberine protected pulmonary arterial rings and cardiac myocytes of rats against hypoxia injury by suppressing NADPH oxidase and calcium influx," Acta Pharmacologica Sinica, vol. 33, no. 5, pp. 625-634, 2012.
15. M.-Y. Qi, Y. Feng, D.-Z. Dai, N. Li, Y.-S. Cheng, and Y. Dai, "CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calciumleakage and downregulated phospholamban and exerting antioxidant activity," Acta Pharmacologica Sinica, vol. 31, no. 2, pp. 165-174, 2010.
16. Y. Yang, W. Duan, Y. Li et al., "New role of silent information regulator 1 in cerebral ischemia," Neurobiology of Aging, vol. 34, no. 12, pp. 2879-2888, 2013.
17. Y. Yang, W. Duan, Y. Li et al., "Novel role of silent information regulator 1 inmyocardial ischemia," Circulation, vol. 128, no. 20, pp. 2232-2240, 2013.
18. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase," Science, vol. 303, no. 5666, pp. 2011-2015, 2004.
19. H. Daitoku, M. Hatta, H. Matsuzaki et al., "Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 27, pp. 10042-10047, 2004.
20. X. Zhu, X. Guo, G. Mao et al., "Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1," Phytotherapy Research, vol. 27, no. 3, pp. 417-421, 2013.
21. A. P. Gomes, F. V. Duarte, P. Nunes et al., "Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1822, no. 2, pp. 185-195, 2012.
22. L. Yu, F. Li, G. Zhao et al., "Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling," Apoptosis, vol. 20, no. 6, pp. 796-810, 2015.
23. Y. Yang, W. Duan, Z. Jin et al., "JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury," Journal of Pineal Research, vol. 55, no. 3, pp. 275-286, 2013.
24. K. Chen, G. Li, F. Geng et al., "Berberine reduces ischemia/ reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats," Apoptosis, vol. 19, no. 6, pp. 946-957, 2014.
25. S. M. Rizk, S. A. El-Maraghy, and N. N. Nassar, "A novel role for SIRT-1 in L-Arginine protection against STZ induced myocardial fibrosis in rats," PLoS ONE, vol. 9, no. 12, Article ID e114560, 2014.
26. H. Su, L. Ji, W. Xing et al., "Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein," Journal of Cellular and Molecular Medicine, vol. 17, no. 1, pp. 181-191, 2013.
27. J. Lin, H. Wang, J. Li et al., "kappa-Opioid receptor stimulation modulates TLR4/NF-kappaB signaling in the rat heart subjected to ischemia-reperfusion," Cytokine, vol. 61, no. 3, pp. 842-848, 2013.
28. X. Wu, B. Zhang, R. Fan et al., "U50, 488H inhibits neutrophil accumulation and TNF-α induction induced by ischemiareperfusion in rat heart," Cytokine, vol. 56, no. 2, pp. 503-507, 2011.
29. T. Zhang, S. Yang, and J. Du, "Protective effects of berberine on isoproterenol-induced acute myocardial ischemia in rats through regulating HMGB1-TLR4 axis," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 849783, 8 pages, 2014.
30. Y.-J. Zhang, S.-H. Yang, M.-H. Li et al., "Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy," Clinical and Experimental Pharmacology and Physiology, vol. 41, no. 12, pp. 995-1002, 2014.
31. M.-H. Li, Y.-J. Zhang, Y.-H. Yu et al., "Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy," European Journal of Pharmacology, vol. 728, no. 1, pp. 67-76, 2014.
32. X. Lv, X. Yu, Y. Wang et al., "Berberine inhibits doxorubicintriggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression," PLoS ONE, vol. 7, no. 10, Article ID e47351, 2012.
33. X.-X. Lv, X.-H. Yu, H.-D. Wang et al., "Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-alpha-caspase signaling pathway," Chinese Journal of Integrative Medicine, vol. 19, no. 6, pp. 424-431, 2013.
34. W. Chang, M. Zhang, J. Li et al., ""Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart," Cardiovascular Drugs and Therapy, vol. 26, no. 6, pp. 467-478, 2012.
35. M. O. Germoush and A. M. Mahmoud, "Berberine mitigates cyclophosphamide-induced hepatotoxicity bymodulating antioxidant status and inflammatory cytokines," Journal of Cancer Research and Clinical Oncology, vol. 140, no. 7, pp. 1103-1109, 2014.
36. A. M. Lefer, X.-L. Ma, A. Weyrich, and D. J. Lefer, "Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury," Agents and Actions Supplements, vol. 41, pp. 127-135, 1993.
37. Y. Tian, H. Li, P. Liu et al., "Captopril pretreatment produces an additive cardioprotection to isoflurane preconditioning in attenuating myocardial ischemia reperfusion injury in rabbits and in humans," Mediators of Inflammation, vol. 2015, Article ID 819232, 12 pages, 2015.
38. Y. Yang, W. Duan, Y. Lin et al., "SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury," Free Radical Biology and Medicine, vol. 65, pp. 667-679, 2013.
39. C.-P. Hsu, P. Zhai, T. Yamamoto et al., "Silent information regulator 1 protects the heart from ischemia/reperfusion," Circulation, vol. 122, no. 21, pp. 2170-2182, 2010.
40. Y. Zhang, X. Liu, Z.-G. She et al., "Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury," Basic Research in Cardiology, vol. 109, no. 5. article 434, 2014.
41. S. Winnik, J. Auwerx, D. A. Sinclair, and C. M. Matter, "Protective effects of sirtuins in cardiovascular diseases: from bench to bedside," European Heart Journal, 2015.
42. M. Vinciguerra, M. P. Santini, C. Martinez et al., "mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart," Aging Cell, vol. 11, no. 1, pp. 139-149, 2012.
43. M. Ruscica, M. Gomaraschi, G. Mombelli et al., "Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus," Journal of Clinical Lipidology, vol. 8, no. 1, pp. 61-68, 2014.
44. R. Sola, R.-M. Valls, J. Puzo et al., "Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: amulticenter randomized trial," PLoS ONE, vol. 9, no. 8, Article ID e101978, 2014.